ECO 2025
11 - 14 May 2025
Pathways to health with GLP-1 receptor agonism – from proteomic footprint to clinical outcomes
Meeting description
Monday, 12 May 2025
13:30 - 13:35
(CEST)
Welcome
Ania Jastreboff
13:35 - 13:50
(CEST)
GLP-1: more than an incretin?
Part 1: Making use of the many facets of GLP-1 mode of action
Part 2: Clinical impact with a proteomic footprint
Christoffer Clemmensen
13:50 - 13:55
(CEST)
Audience polling
13:55 - 14:10
(CEST)
Health improvements with GLP-1 receptor agonism beyond weight
Kirsi Pietiläinen
14:10 - 14:15
(CEST)
Audience polling
14:15 - 14:30
(CEST)
New pathways to health: Have we unlocked the full potential of GLP-1RAs?
Filip Knop
14:30 - 14:35
(CEST)
Audience polling
14:35 - 14:55
(CEST)
Panel discussion: Addressing opportunities and future directions with GLP-1RA therapy
Ania Jastreboff, Christoffer Clemmensen, Kirsi Pietiläinen, Filip Knop
14:55 - 15:00
(CEST)
Closing remarks
Ania Jastreboff
Keywords